Asaf Danziger
Net Worth
Last updated:
What is Asaf Danziger net worth?
The estimated net worth of Mr. Asaf Danziger is at least $88,970,238 as of 5 Jan 2023. He owns shares worth $163,797 as insider, has earned $70,716,441 from insider trading and has received compensation worth at least $18,090,000 in NovoCure Limited.
What is the salary of Asaf Danziger?
Mr. Asaf Danziger salary is $2,010,000 per year as Pres, Chief Executive Officer & Director in NovoCure Limited.
How old is Asaf Danziger?
Mr. Asaf Danziger is 59 years old, born in 1966.
What stocks does Asaf Danziger currently own?
As insider, Mr. Asaf Danziger owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
NovoCure Limited (NVCR) | Pres, Chief Executive Officer & Director | 13,583 | $12.06 | $163,797 |
What does NovoCure Limited do?
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Asaf Danziger insider trading
NovoCure Limited
Mr. Asaf Danziger has made 66 insider trades between 2016-2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 354,780 units of NVCR stock on 14 Jul 2017. As of 5 Jan 2023 he still owns at least 13,583 units of NVCR stock.
NovoCure Limited key executives
NovoCure Limited executives and other stock owners filed with the SEC:
- Mr. Asaf Danziger (59) Pres, Chief Executive Officer & Director
- Mr. Pritesh Shah (47) Chief Commercial Officer
- Mr. Todd C. Longsworth (50) Gen. Counsel
- Mr. Wilhelmus C. M. Groenhuysen (67) Chief Operating Officer
- Mr. William F. Doyle (63) Executive Chairman
- Ms. Ashley Cordova (46) Chief Financial Officer & Vice President of Investor Relations